These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 26936880)
21. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. Sinha P; Clements VK; Bunt SK; Albelda SM; Ostrand-Rosenberg S J Immunol; 2007 Jul; 179(2):977-83. PubMed ID: 17617589 [TBL] [Abstract][Full Text] [Related]
22. Spleen tyrosine kinase-dependent Nrf2 activation regulates oxidative stress-induced cell death in WiL2-NS human B lymphoblasts. Park S; Jang JW; Moon EY Free Radic Res; 2018 Sep; 52(9):977-987. PubMed ID: 30203714 [TBL] [Abstract][Full Text] [Related]
23. TNF Receptor-2 Facilitates an Immunosuppressive Microenvironment in the Liver to Promote the Colonization and Growth of Hepatic Metastases. Ham B; Wang N; D'Costa Z; Fernandez MC; Bourdeau F; Auguste P; Illemann M; Eefsen RL; Høyer-Hansen G; Vainer B; Evrard M; Gao ZH; Brodt P Cancer Res; 2015 Dec; 75(24):5235-47. PubMed ID: 26483205 [TBL] [Abstract][Full Text] [Related]
24. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Le HK; Graham L; Cha E; Morales JK; Manjili MH; Bear HD Int Immunopharmacol; 2009 Jul; 9(7-8):900-9. PubMed ID: 19336265 [TBL] [Abstract][Full Text] [Related]
25. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα. Sinha P; Parker KH; Horn L; Ostrand-Rosenberg S Eur J Immunol; 2012 Aug; 42(8):2052-9. PubMed ID: 22673957 [TBL] [Abstract][Full Text] [Related]
26. Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract. Sinha P; Ostrand-Rosenberg S Cancer Immunol Immunother; 2013 Nov; 62(11):1663-73. PubMed ID: 23982485 [TBL] [Abstract][Full Text] [Related]
29. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314 [TBL] [Abstract][Full Text] [Related]
30. HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. Parker KH; Sinha P; Horn LA; Clements VK; Yang H; Li J; Tracey KJ; Ostrand-Rosenberg S Cancer Res; 2014 Oct; 74(20):5723-33. PubMed ID: 25164013 [TBL] [Abstract][Full Text] [Related]
31. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells. Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469 [TBL] [Abstract][Full Text] [Related]
32. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors. Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342 [TBL] [Abstract][Full Text] [Related]
33. Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. Zhu H; Klement JD; Lu C; Redd PS; Yang D; Smith AD; Poschel DB; Zou J; Liu D; Wang PG; Ostrov D; Coant N; Hannun YA; Colby AH; Grinstaff MW; Liu K J Immunol; 2021 Mar; 206(6):1395-1404. PubMed ID: 33547170 [TBL] [Abstract][Full Text] [Related]
34. Aptamer-mediated blockade of IL4Rα triggers apoptosis of MDSCs and limits tumor progression. Roth F; De La Fuente AC; Vella JL; Zoso A; Inverardi L; Serafini P Cancer Res; 2012 Mar; 72(6):1373-83. PubMed ID: 22282665 [TBL] [Abstract][Full Text] [Related]
35. COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function. Veltman JD; Lambers ME; van Nimwegen M; Hendriks RW; Hoogsteden HC; Aerts JG; Hegmans JP BMC Cancer; 2010 Aug; 10():464. PubMed ID: 20804550 [TBL] [Abstract][Full Text] [Related]